Monopar Therapeutics Inc (MNPR) has issued an update.
Monopar Therapeutics Inc. has recently announced an update to their collaboration with NorthStar Medical Radioisotopes, LLC, revealing an expansion and amendment of their existing partnership. This development signifies a strengthening of the bond between the two companies and could have implications for their future projects and stock performance.
See more insights into MNPR stock on TipRanks’ Stock Analysis page.
